Background: Triphenyl phosphate (TPhP) is an environmental PPARγ ligand, and growing evidence suggests that it is a metabolic disruptor. We have shown previously that the structurally similar ligand, tributyltin, does not induce brite adipocyte gene expression.Objectives: First, we tested whether TPhP also fails to induce brite adipogenesis in vivo, in human primary preadipocytes and in 3T3 L1 cells. Second, we tested the hypothesis that TPhP is a selective PPARγ modulator that is unable to protect PPARγ from phosphorylation at serine 273.Methods: C57BL/6J male mice were fed either a low or very high fat diet for 13 weeks. From weeks 7-13, mice were injected intraperitoneally, daily, with vehicle, rosiglitazone (Rosi), or TPhP (10 mg/kg). Mature adipocytes were isolated from inguinal adipose tissue to assess adipocyte gene expression. Adipocyte genotype and phenotype were assessed in human primary preadipocytes differentiated in the presence of Rosi, or TPhP. Adipocyte gene and protein expression were determined in 3T3 L1 cells differentiated in the presence of Rosi or TPhP. Swiss 3T3 cell lines expressing wild-type PPARγ2 or PPARγ2 with alanine substitute for serine at position 273 were used to determine effects of PPARγ phosphorylation on Rosiand TPhP-induced gene expression.Results: Compared to Rosi, TPhP did not induce browning of mature adipocytes. TPhP also did not induce expression of brite adipocyte genes, mitochondrial biogenesis or cellular respiration in primary human adipocytes. Rosi and TPhP induced distinct proteomic and phosphoproteomic profiles; Rosi enriched more regulatory pathways related to fatty acid oxidation and mitochondrial proteins. Furthermore, TPhP maintained phosphorylation of PPARγ at ser273. Upon inhibition of phosphorylation at ser273, TPhP was able to induce brite adipocyte genes.Discussion: Here, we show that TPhP acts via a novel mechanism of action. TPhP disrupts brite adipocyte differentiation by failing to protect PPARγ from phosphorylation at ser273, in contrast to the therapeutic PPARγ ligand Rosi.